Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Indian Journal of Medical and Paediatric Oncology
Search Article 
  
Advanced search 
 

    Article Cited by others

ORIGINAL ARTICLE

Gemcitabine and cisplatin-based combination chemotherapy in advanced hepatocellular carcinoma: An Indian experience

Pande Shripad B, Doval D C, Pavithran K, Sharma J B, Shirali Rashmi, Jena A

Year : 2012| Volume: 33| Issue : 1 | Page no: 42-47

   This article has been cited by
 
1 The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: ThePuri Recommendations
Ashish Kumar,Subrat K. Acharya,Shivaram P. Singh,Vivek A. Saraswat,Anil Arora,Ajay Duseja,Mahesh K. Goenka,Deepali Jain,Premashish Kar,Manoj Kumar,Vinay Kumaran,Kunisshery M. Mohandas,Dipanjan Panda,Shashi B. Paul,Jeyamani Ramachandran,Hariharan Ramesh,Padaki N. Rao,Samir R. Shah,Hanish Sharma,Ragesh B. Thandassery
Journal of Clinical and Experimental Hepatology. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
Wu, Q., Wang, R., Yang, Q.,Chen, Y., Wang, Z.
Oncotarget. 2013; 4(11): 1999-2009
[Pubmed]  [Google Scholar]
3 Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside
Omar Abdel-Rahman
Journal of the Egyptian National Cancer Institute. 2013; 25(4): 165
[Pubmed]  [Google Scholar] [DOI]

 

Read this article